Candida biofilms and oral candidosis: Treatment and prevention

Periodontology 2000

Volumn 55, Issue 1, 2011, Pages 250-265

  Williams, David W ^a   Kuriyama, Tomoari ^a   Silva, Sonia ^a   Malic, Sladjana ^a   Lewis, Michael A O ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; VIRULENCE FACTOR;

AGE; ARTICLE; BIOFILM; CANDIDA; CELL ADHESION; CELL PROLIFERATION; DENTURE; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOCOMPROMISED PATIENT; MOUTH HYGIENE; PATHOLOGY; PHYSIOLOGY; THRUSH;

AGE FACTORS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA; CANDIDIASIS, ORAL; CELL ADHESION; CELL PROLIFERATION; DENTURES; HUMANS; IMMUNOCOMPROMISED HOST; ORAL HYGIENE; VIRULENCE FACTORS;

EID: 78650058705     PISSN: 09066713     EISSN: 16000757     Source Type: Journal    
DOI: 10.1111/j.1600-0757.2009.00338.x     Document Type: Article

References (126)

1. Abu-Elteen KH, Abu-Alteen RM. The prevalence of Candida albicans populations in the mouths of complete denture wearers. New Microbiol 1998: 21: 41-48.
2. Akpan A, Morgan R. Oral candidiasis. Postgrad Med J 2002: 78: 455-459.
3. Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother 2004: 48: 3291-3297.
4. Al-Fattani MA, Douglas LJ. Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance. J Med Microbiol 2006: 55: 999-1008.
5. Alem MA, Oteef MD, Flowers TH, Douglas LJ. Production of tyrosol by Candida albicans biofilms and its role in quorum sensing and biofilm development. Eukaryot Cell 2006: 5: 1770-1779.
6. Atkinson BJ, Lewis RE, Kontoyiannis DP. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Med Mycol 2008: 46: 541-546.
7. Baillie GS, Douglas LJ. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 1998: 42: 1900-1905.
8. Baillie GS, Douglas LJ. Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 2000: 46: 397-403.
9. Barbeau J, Seguin J, Goulet JP, De Koninck L, Avon SL, Lalond B, Rompre P, Deslauries N. Reassessing the presence of Candida albicans in denture-related stomatitis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003: 95: 51-59.
10. Barkvoll P, Attramadal A. Effect of nystatin and chlorhexidine digluconate on Candida albicans. Oral Surg Oral Med Oral Pathol 1989: 67: 279-281.
11. Barnett JA. A history of research on yeasts 12: medical yeasts part 1, Candida albicans. Yeast 2008: 25: 385-417.
12. Barrett AW, Kingsmill VJ, Speight PM. The frequency of fungal infection in biopsies of oral mucosal lesions. Oral Dis 1998: 4: 26-31.
13. Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MAO. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol 2004: 19: 293-296.
14. Bassetti M, Ansaldi F, Nicolini L, Malfatto E, Molinari MP, Mussap M, Rebesco B, Bobbio Pallavicini F, Icardi G, Viscoli C. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. J Antimicrob Chemother 2009: 64: 625-629.
15. Budtz-Jorgensen E. Etiology, pathogenesis, therapy, and prophylaxis of oral yeast infections. Acta Odontol Scand 1990: 48: 61-69.
16. Bulad K, Taylor RL, Verran J, McCord JF. Colonization and penetration of denture soft lining materials by Candida albicans. Dent Mater 2004: 20: 167-175.
17. Campisi G, Panzarella V, Matranga D, Calvino F, Pizzo G, Lo Muzio L, Porter S. Risk factors of oral candidosis: a twofold approach of study by fuzzy logic and traditional statistic. Arch Oral Biol 2008: 53: 388-397.
18. Cardinal E, Braunstein EM, Capello WN, Heck DA. Candida albicans infection of prosthetic joints. Orthopedics 1996: 19: 247-251.
19. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ, Ghannoum MA. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro. J Dent Res 2001: 80: 903-908.
20. Chandra J, Patel JD, Li J, Zhou G, Mukherjee PK, McCormick TS, Anderson JM, Ghannoum MA. Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl Environ Microbiol 2005: 71: 8795-8801.
21. Chen H, Fujita M, Feng Q, Clardy J, Fink GR. Tyrosol is a quorum sensing molecule in Candida albicans. Proc Natl Acad Sci USA 2004: 101: 5048-5052.
22. Colombo AL, Nucci M, Park BJ, Nouér SA, Arthington-Skaggs B, Dab Matta DA, Warnock D, Morgan J, Brazilian Network Candidemia Study. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J Clin Microbiol 2006: 44: 2816-2823.
23. Corpus K, Hegeman-Dingle R, Bajjoka I. Candida kefyr, an uncommon but emerging fungal pathogen: report of two cases. Pharmacotherapy 2004: 24: 1084-1088.
24. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ. Bacterial biofilms in nature and disease. Annu Rev Microbiol 1987: 41: 435-464.
25. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol 1995: 49: 711-745.
26. Crump JA, Collignon PJ. Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 2000: 19: 1-8.
27. Dongari-Bagtzoglou A. Mucosal biofilms: challenges and future directions. Expert Rev Anti Infect Ther 2008: 6: 141-144.
28. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003: 11: 30-36.
29. Egusa H, Soysa NS, Ellepola AN, Yatani H, Samaranayake LP. Oral candidosis in HIV-infected patients. Curr HIV Res 2008: 6: 485-499.
30. Ellepola ANB, Samaranayake LP. Oral candidal infections and antimycotics. Crit Rev Oral Biol Med 2000: 11: 172-198.
31. Everaert EP, Mahieu HF, Van de Belt-Gritter B, Peeters AJ, Verkerke GJ, Van der Mei HC, Busscher HJ. Biofilm formation in vivo on perfluoro-alkylsiloxane-modified voice prostheses. Arch Otolaryngol Head Neck Surg 1999: 125: 1329-1332.
32. Figueiral MH, Azul A, Pinto E, Fonseca PA, Branco FM, Scully C. Denture-related stomatitis: identification of aetiological and predisposing factors - a large cohort. J Oral Rehabil 2007: 34: 448-455.
33. Filoche SK, Soma K, Sissons CH. Antimicrobial effects of essential oils in combination with chlorhexidine digluconate. Oral Microbiol Immunol 2005: 20: 221-225.
34. Fine DH. Mouthrinses as adjuncts for plaque and gingivitis management. A status report for the American Journal of Dentistry. Am J Dent 1988: 1: 259-263.
35. Fine DH, Markowitz K, Furgang D, Goldsmith D, Charles CH, Lisante TA, Lynch MC. Effect of an essential oil-containing antimicrobial mouthrinse on specific plaque bacteria in vivo. J Clin Periodontol 2007: 34: 652-657.
36. Fukushima C, Matsuse H, Saeki S, Kawano T, Machida I, Kondo Y, Kohno S. Salivary IgA and oral candidiasis in asthmatic patients treated with inhaled corticosteroid. J Asthma 2005: 42: 601-604.
37. Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 2003: 90: 646-651.
38. Geerts GAVM, Stuhlinger ME, Basson NJ. Effect of an antifungal denture liner on the saliva yeast count in patients with denture stomatitis: a pilot study. J Oral Rehab 2008: 35: 664-669.
39. González GM, Elizondo M, Ayala J. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J Clin Microbiol 2008: 46: 2902-2905.
40. Grbic JT, Mitchell-Lewis DA, Fine JB, Phelan JA, Bucklan RS, Zambon JJ, Lamster IB. The relationship of candidiasis to linear gingival erythema in HIV-infected homosexual men and parenteral drug users. J Periodontol 1995: 66: 30-37.
41. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington-Skaggs BA, Mirza SA, Phelan M, Morgan J, Lee-Yang W, Ciblak MA, Benjamin LE, Sanza LT, Huie S, Yeo SF, Brandt ME, Warnock DW. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program. J Clin Microbiol 2004: 42: 1519-1527.
42. Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T, Meurman JH, Korpela R. Probiotics reduce the prevalence of oral Candida in the elderly - a randomized controlled trial. J Dent Res 2007: 86: 125-130.
43. Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 1995: 39: 2128-2131.
44. Hazen KC, Theisz GW, Howell SA. Chronic urinary tract infection due to Candida utilis. J Clin Microbiol 1999: 37: 824-827.
45. Hope CK, Wilson M. Effects of dynamic fluid activity from an electric toothbrush on in vitro oral biofilms. J Clin Periodontol 2003: 30: 624-629.
46. Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009: 48: 1695-1703.
47. Hornby JM, Jensen EC, Lisec AD, Tasto JJ, Jahnke B, Shoemaker R, Dussault P, Nickerson KW. Quorum sensing in the dimorphic fungus Candida albicans is mediated by farnesol. Appl Environ Microbiol 2001: 67: 2982-2992.
48. Jabra-Rizk MA, Shirtliff M, James C, Meiller T. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance. FEMS Yeast Res 2006: 6: 1063-1073.
49. Jain N, Kohli R, Cook E, Gialanella P, Chang T, Fries BC. Biofilm formation by and antifungal susceptibility of Candida isolates from urine. Appl Environ Microbiol 2007: 73: 1697-1703.
50. Jayatilake JA, Samaranayake YH, Cheung LK, Samaranayake LP. Quantitative evaluation of tissue invasion by wild type, hyphal and SAP mutants of Candida albicans, and non-albicans Candida species in reconstituted human oral epithelium. J Oral Pathol Med 2006: 35: 484-491.
51. Khardori N, Yassien M. Biofilms in device-related infections. J Ind Microbiol 1995: 15: 141-147.
52. Kim MN, Shin JH, Sung H, Lee K, Kim EC, Ryoo N, Lee JS, Jung SI, Park KH, Kee SJ, Kim SH, Shin MG, Suh SP, Ryang DW. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. Clin Infect Dis 2009: 48: e57-e61.
53. Kimura LH, Pearsall NN. Relationship between germination of Candida albicans and increased adherence to human buccal epithelial cells. Infect Immun 1980: 28: 464-468.
54. Kornman KS. Diagnostic and prognostic tests for oral diseases: practical applications. J Dent Educ 2005: 69: 498-508.
55. Krcméry V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect 2002: 50: 243-260.
56. Krcméry V, Kunová A. Candida famata fungemia in a cancer patient: case report. J Chemother 2000: 12: 189-190.
57. Kubert D, Rubin M, Barnett ML, Vincent JW. Antiseptic mouthrinse-induced microbial cell surface alterations. Am J Dent 1993: 6: 277-279.
58. Kuriyama T, Williams DW, Lewis MAO. In vitro secreted aspartyl proteinase activity of Candida albicans isolated from oral diseases and healthy oral cavities. Oral Microbiol Immunol 2003: 18: 405-407.
59. LaFleur MD, Kumamoto CA, Lewis K. Candida albicans biofilms produce antifungal-tolerant persister cells. Antimicrob Agents Chemother 2006: 50: 3839-3846.
60. Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009: 52: 197-205.
61. Leonhardt A, Renvert S, Dahlén G. Microbial findings at failing implants. Clin Oral Implants Res 1999: 10: 339-345.
62. Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006). Crit Care Med 2009: 37: 1612-1618.
63. Li L, Redding S, Dongari-Bagtzoglou A. Candida glabrata: an emerging oral opportunistic pathogen. J Dent Res 2007: 86: 204-215.
64. Liguori G, Di Onofrio V, Lucariello A, Gallé F, Signoriello G, Colella G, D'Amora M, Rossano F. Oral candidiasis: a comparison between conventional methods and multiplex polymerase chain reaction for species identification. Oral Microbiol Immunol 2009: 24: 76-78.
65. Machado A, Breeding L, Vergani C, Da Cruz Perez L. Hardness and surface roughness of reline and denture base acrylic resins after repeated disinfection procedures. J Prosthet Dent 2009: 102: 115-122.
66. MacNeill S, Rindler E, Walker A, Brown AR, Cobb CM. Effects of tetracycline hydrochloride and chlorhexidine gluconate on Candida albicans: an in vitro study. J Clin Periodontol 1997: 24: 753-760.
67. Malic S, Hill KE, Ralphs JR, Hayes A, Thomas DW, Potts AJ, Williams DW. Characterization of Candida albicans infection of an in vitro oral epithelial model using confocal laser scanning microscopy. Oral Microbiol Immunol 2007: 22: 188-194.
68. Martins M, Henriques M, Azeredo J, Rocha SM, Coimbra MA, Oliveira R. Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells. Eukaryot Cell 2007: 6: 2429-2436.
69. Mateus C, Crow SA Jr, Ahearn DG. Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother 2004: 48: 3358-3366.
70. Meurman JH. Probiotics: do they have a role in oral medicine and dentistry? Eur J Oral Sci 2005: 113: 188-196.
71. Miranda LN, Van der Heijden IM, Costa SF, Sousa AP, Sienra RA, Gobara S, Santos CR, Lobo RD, Pessoa VP Jr, Levin AS. Candida colonisation as a source for candidaemia. J Hosp Infect 2009: 72: 9-16.
72. Mokaddas EM, Al-Sweih NA, Khan ZU. Species distribution and antifungal susceptibility of Candida bloodstream isolates in Kuwait: a 10-year study. J Med Microbiol 2007: 56: 255-259.
73. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols. Infect Immun 2003: 71: 4333-4440.
74. Nair PN, Sjögren U, Krey G, Kahnberg KE, Sundqvist G. Intraradicular bacteria and fungi in root-filled, asymptomatic human teeth with therapy-resistant periapical lesions: a long-term light and electron microscopic follow-up study. J Endod 1990: 16: 580-588.
75. Nett JE, Lepak AJ, Marchillo K, Andes DR. Time course global gene expression analysis of an in vivo Candida biofilm. J Infect Dis 2009: 200: 307-313.
76. Netuschil L, Weiger R, Preisler R, Brecx M. Plaque bacteria counts and vitality during chlorhexidine, meridol and listerine mouthrinses. Eur J Oral Sci 1995: 103: 355-361.
77. Nickerson KW, Atkin AL, Hornby JM. Quorum sensing in dimorphic fungi: farnesol and beyond. Appl Environ Microbiol 2006: 72: 3805-3813.
78. Nobile CJ, Schneider HA, Nett JE, Sheppard DC, Filler SG, Andes DR, Mitchell AP. Complementary adhesin function in C. albicans biofilm formation. Curr Biol 2008: 18: 1017-1024.
79. Odds FC. Candida and Candidosis, 2nd Edn. London: Bailliere Tindall, 1988.
80. Odds FC. Pathogenesis of Candida infections. J Am Acad Dermatol 1994: 31: S2-S5.
81. Olsen I. Denture stomatitis, occurrence and distribution of fungi. Acta Odontol Scand 1974: 32: 329-333.
82. Pan PH, Finnegan MB, Sturdivant L, Barnett ML. Comparative antimicrobial activity of an essential oil and an amine fluoride/stannous fluoride mouthrinse in vitro. J Clin Periodontol 1999: 26: 474-476.
83. Parahitiyawa NB, Samaranayake YH, Samaranayake LP, Ye J, Tsang PW, Cheung BP, Yau JY, Yeung SK. Interspecies variation in Candida biofilm formation studied using the Calgary biofilm device. APMIS 2006: 114: 298-306.
84. Pizzo G, La Cara M, Licata ME, Pizzo I, D'Angelo M. The effects of an essential oil and an amine fluoride/stannous fluoride mouthrinse on supragingival plaque regrowth. J Periodontol 2008: 79: 1177-1183.
85. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiases: a persistent public health problem. Clin Microbiol Rev 2007: 20: 133-163.
86. Price CL, Waters MG, Williams DW, Lewis MAO, Stickler D. Surface modification of an experimental silicone rubber aimed at reducing initial candidal adhesion. J Biomed Mater Res 2002: 63: 122-128.
87. Price CL, Williams DW, Waters MG, Coulthwaite L, Verran J, Taylor RL, Stickler D, Lewis MAO. Reduced adherence of Candida to silane-treated silicone rubber. J Biomed Mater Res B Appl Biomater 2005: 74: 481-487.
88. Pusateri CR, Monaco EA, Edgerton M. Sensitivity of Candida albicans biofilm cells grown on denture acrylic to antifungal proteins and chlorhexidine. Arch Oral Biol 2009: 54: 588-594.
89. Radfar L, Shea Y, Fischer SH, Sankar V, Leakan RA, Baum BJ, Pillemer SR. Fungal load and candidiasis in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003: 96: 283-287.
90. Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 2006: 6: 979-986.
91. Ramage G, Saville PS, Thomas PD, López-Ribot JL. Candida biofilms: an update. Eukaryot Cell 2005: 4: 633-638.
92. Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL. In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies. Antimicrob Agents Chemother 2002: 46: 3634-3636.
93. Redding S, Bhatt B, Rawls HR, Siegel G, Scott K, Lopez-Ribot J. Inhibition of Candida albicans biofilm formation on denture material. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009: 107: 669-672.
94. Renstrup G. Occurrence of Candida in oral leukoplakias. Acta Pathol Microbiol Scand B Microbiol Immunol 1970: 78: 421-424.
95. Rüping MJ, Vehreschild JJ, Cornely OA. Patients at high risk of invasive fungal infections: when and how to treat. Drugs 2008: 68: 1941-1962.
96. Salamon SA, Fuursted K, Egeblad H, Petersen E, Ott P. Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery. Scand J Infect Dis 2007: 39: 641-644.
97. Salles AES, Macedo LD, Fernandes RAG, Silva-Lovato CH, Paranhos HdeFO. Comparative analysis of biofilm levels in complete upper and lower dentures after brushing associated with specific denture paste and neutral soap. Gerodontology 2007: 24: 217-223.
98. Sakashita S, Takayama K, Nishioka K, Katoh T. Taste disorders in healthy 'carriers' and 'non-carriers' of Candida albicans and in patients with candidosis of the tongue. J Dermatol 2004: 31: 890-897.
99. Samaranayake LP. Superficial oral fungal infections. Curr Opin Dent 1991: 1: 415-422.
100. Samaranayake LP. Nutritional factors and oral candidosis. J Oral Pathol 1986: 15: 61-65.
101. Samaranayake LP, Keung Leung W, Jin L. Oral mucosal fungal infections. Periodontol 2000 2009: 49: 39-59.
102. Samaranayake LP, Lamb AB, Lamey PJ, MacFarlane TW. Oral carriage of Candida species and coliforms in patients with burning mouth syndrome. J Oral Pathol Med 1989: 18: 233-235.
103. Samaranayake LP, MacFarlane TW. Factors affecting the in-vitro adherence of the fungal oral pathogen Candida albicans to epithelial cells of human origin. Arch Oral Biol 1982: 27: 869-873.
104. Samaranayake YH, Samaranayake LP. Candida krusei: biology, epidemiology, pathogenicity and clinical manifestations of an emerging pathogen. J Med Microbiol 1994: 41: 295-310.
105. Sanglard D, Ischer F, Marchetti O, Entenza J, Bille J. Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 2003: 48: 959-976.
106. Shchepin R, Hornby JM, Burger E, Niessen T, Dussault P, Nickerson KW. Quorum sensing in Candida albicans: probing farnesol's mode of action with 40 natural and synthetic farnesol analogs. Chem Biol 2003: 10: 743-750.
107. Shimizu C, Kuriyama T, Williams DW, Karasawa T, Inoue K, Nakagawa K, Yamamoto E. Association of oral yeast carriage with specific host factors and altered mouth sensation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008: 105: 445-451.
108. Shin JH, Kook H, Shin DH, Hwang TJ, Kim M, Suh SP, Ryang DW. Nosocomial cluster of Candida lipolytica fungemia in pediatric patients. Eur J Clin Microbiol Infect Dis 2000: 19: 344-349.
109. Sitheeque MA, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med 2003: 14: 253-267.
110. Smith AJ, Robertson D, Tang MK, Jackson MS, MacKenzie D, Bagg J. Staphylococcus aureus in the oral cavity: a three-year retrospective analysis of clinical laboratory data. Br Dent J 2003: 195: 701-703.
111. Soysa NS, Samaranayake LP, Ellepola AN. Diabetes mellitus as a contributory factor in oral candidosis. Diabet Med 2006: 23: 455-459.
112. Soysa NS, Samaranayake LP, Ellepola AN. Antimicrobials as a contributory factor in oral candidosis - a brief overview. Oral Dis 2008: 14: 138-143.
113. Sugar AM, Stevens DA. Candida rugosa in immunocompromised infection: case reports, drug susceptibility and review of the literature. Cancer 1985: 56: 318-320.
114. Sullivan DJ, Moran GP, Coleman DC. Candida dubliniensis: ten years on. FEMS Microbiol Lett 2005: 253: 9-17.
115. Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008: 21: 606-625.
116. Tumbarello M, Posteraro B, Trecarichi EM, Fiori B, Rossi M, Porta R, De Gaetano Donati K, La Sorda M, Spanu T, Fadda G, Cauda R, Sanguinetti M. Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 2007: 45: 1843-1850.
117. Van der Mei HC, Free RH, Elving GJ, Van Weissenbruch R, Albers FW, Busscher HJ. Effect of probiotic bacteria on prevalence of yeasts in oropharyngeal biofilms on silicone rubber voice prostheses in vitro. J Med Microbiol 2000: 49: 713-718.
118. Van Weissenbruch R, Bouckaert S, Remon JP, Nelis HJ, Aerts R, Albers FW. Chemoprophylaxis of fungal deterioration of the Provox silicone tracheoesophageal prosthesis in postlaryngectomy patients. Ann Otol Rhinol Laryngol 1997: 106: 329-337.
119. Velegraki A, Nicolatou O, Theodoridou M, Mostrou G, Legakis NJ. Paediatric AIDS-related linear gingival erythema: a form of erythematous candidiasis? J Oral Pathol Med 1999: 28: 178-182.
120. Verran J, Maryan CJ. Retention of Candida albicans on acrylic resin and silicone of different surface topography. J Prosthet Dent 1997: 77: 535-539.
121. Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR, Otto M. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J Biol Chem 2004: 279: 54881-54886.
122. Walker DM, Arendorf T. Oral candidosis. In: Samaranayake LP, MacFarlane TW editors. Candidal Leukoplakia, Chronic Multifocal Candidosis and Median Rhomboid Glossitis. London: Wright, 1990: 184-199.
123. Webb BC, Thomas CJ, Whittle T. A 2-year study of Candida associated denture stomatitis treatment in aged care subjects. Gerodontology 2005: 22: 168-176.
124. Weerasuriya N, Snape J. Oesophageal candidiasis in elderly patients: risk factors, prevention and management. Drugs Aging 2008: 25: 119-130.
125. Williams DW, Potts AJ, Wilson MJ, Matthews JB, Lewis MAO. Characterisation of the inflammatory cell infiltrate in chronic hyperplastic candidosis of the oral mucosa. J Oral Pathol Med 1997: 26: 83-89.
126. Yeater KM, Chandra J, Cheng G, Mukherjee PK, Zhao X, Rodriguez-Zas SL, Kwast KE, Ghannoum MA, Hoyer LL. Temporal analysis of Candida albicans gene expression during biofilm development. Microbiology 2007: 153: 2373-2385.